Legal Representation
Attorney
Catherine Dugan O'Connor
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 4, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Oct 4, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jul 1, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 1, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jul 1, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 1, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 23, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 23, 2022 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 23, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 17, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 16, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 16, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 14, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 14, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 14, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Aug 19, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 19, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 19, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 19, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 30, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 2, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical test kits for molecular test for medical laboratory or medical research use in the field of infectious, viral, communicable, respiratory, inflammatory, immunological, and autoimmune diseases; Diagnostic reagents for clinical or medical laboratory use in the field of infectious, viral, communicable, respiratory, inflammatory, immunological, and autoimmune diseases; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology in the field of infectious, viral, communicable, respiratory, inflammatory, immunological, and autoimmune diseases; Diagnostic reagents for scientific or research use in the field of infectious, viral, communicable, respiratory, inflammatory, immunological, and autoimmune diseases; Reagent paper other than for medical purposes; Reagents for scientific and research use in the field of infectious, viral, communicable, respiratory, inflammatory, immunological, and autoimmune diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Reagent paper for medical purposes; Diagnostic biomarker reagents for medical purposes; medical diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Medical diagnostic reagents
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005